Onkologie. 2010:4(3):159-161

Fertility preservation strategies in Hodgkin´s lymphoma patients

Lenka ©mardová1, Martin Huser2, Zdeněk Král1, Igor Crha2
1 Interní hematoonkologická klinika FN a LF MU, Brno
2 Gynekologicko-porodnická klinika FN a LF MU, Brno

Oncological therapy often entails a permanent disability, one of the most frequent is infertility based on the irreversible damage to gonads.

In the summary article there are summarized the contemporary possibilities of the protection of testicular and ovarian functions

in the Hodgkin´s lymphoma patients undergoing the oncological treatment.

Keywords: fertility, testicular dysfunction, ovarian dysfunction, cryoconservation, gonadoliberine analogues

Published: July 1, 2010  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
©mardová L, Huser M, Král Z, Crha I. Fertility preservation strategies in Hodgkin´s lymphoma patients. Onkologie. 2010;4(3):159-161.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Schrader M, Heicappell R, Muller M, et al. Impact of chemotherapy on male fertility. Onkologie 2001; 24: 326-330. Go to original source... Go to PubMed...
    2. Barr RD, Clark DA, Booth JD. Dyspermia in men with localized Hodgkin's disease. A potentially reversible, immune-mediated disorder. Medical hypotheses 1993; 40: 165-168. Go to original source... Go to PubMed...
    3. Schrader M, Heicappell R, Muller M, et al. Impact of chemotherapy on male fertility. Onkologie 2001; 24: 326-330. Go to original source... Go to PubMed...
    4. Crha I, Ventruba P, Zakova J, et al. Survival and infertility treatment in male cancer patients after sperm banking. Fertility and sterility 2009; 91: 2344-2348. Go to original source... Go to PubMed...
    5. ©lampa P, Petera J, et al. Radiační onkologie. Praha: Galén 2007.
    6. Chan P, Palermo G, Veeck L, et al. Testicular sperm extraction combined with intracytoplasmic sperm injection in the treatment of men with persistant azoospermia postchemotherapy. Cancer 2001; 92: 1632-1637. Go to original source...
    7. Laml T, Schulz-Lobmeyr I, Obruca A, et al. Premature ovarian failure: etiology and prospects. Gynecol Endocrinol 2000; 14: 292-302. Go to original source... Go to PubMed...
    8. Franchi-Rezgui P, Rousselot P, Espie M, et al. Fertility in young women after chemotherapy with alkylating agents for Hodgkin and non-Hodgkin lymphomas. Hematolog J 2003; 4: 116-120. Go to original source... Go to PubMed...
    9. Huser M, Juránková E, Crha I, et al. Kryokonzervace ovariální tkáně - ąance na záchranu fertility ľen s nádorovým onemocněním. Česká Gynekologie 2007; 72: 68-73. Go to PubMed...
    10. Meirow D, Levron J, Eldar-Geva T, et al. Pregnancy after transplantation of cryopreserved ovarian tissue in a patient with ovarian failure after chemotherapy. The New England journal of medicine 2005; 353: 318-321. Go to original source... Go to PubMed...
    11. Blumenfeld Z, Avivi I, Ritter M. Preservation of fertility and ovarian function and minimizing chemotherapy-induced gonadotoxicity in young women. J Soc Gynecol Invest 1999; 6: 229-239. Go to original source... Go to PubMed...
    12. Anselmo A, Cavalieri E, Aragona C, et al. Successful pregnancies following an egg donation program in women with previously treated Hodgkin´s disease. Haematologica 2001; 86: 624-628. Go to PubMed...
    13. Huser M, Crha I, Ventruba P, et al. Prevention of ovarian function damage by a GnRH analogue during chemotherapy in Hodgkin lymphoma patients. Hum Reprod 2008; 23: 863-868. Go to original source... Go to PubMed...

    Return to the content


    Oncology

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.